- Patient Square Capital completes $2.6 billion take-private acquisition of Premier, Inc (NASD: PINC), paying $28.25 per share in all-cash deal. The deal takes Premier private and keeps its operations focused on powering healthcare improvement through analytics, supply chain offerings, collaboratives, and advisory services. As part of a larger healthcare-focused portfolio, the company is expected to use additional capital and expertise to enhance technology-driven tools that help providers improve outcomes and reduce costs. (Link)
- Bruker Corporation (NASD: BRKR) acquires AST Revolution to advance WAVE and Arc rapid antimicrobial susceptibility testing technologies and expand clinical diagnostics portfolio The deal shifts a revitalized rapid testing platform into a larger diagnostics ecosystem, keeping focus on delivering quicker, clinically actionable antimicrobial susceptibility results. With prior investment having stabilized and advanced the WAVE and Arc systems, the new owner is expected to use its scale, market access, and technical depth to speed adoption in laboratories and hospitals. (Link)
- MDI NetworX acquires Cobalt MedPlans (Clarity Performance Solutions) from Cobalt Health Solutions, a Blue Cross and Blue Shield of Kansas City Subsidiary, to Expand U.S. Payer Services and Deploy InsightPro AI Platform The deal adds 250 U.S. staff and two Kansas delivery centers, lifting the company’s global workforce above 7,500 and growing its domestic operations to four sites. It plans to intensify investment in automation, analytics, and workforce capabilities to deliver scalable, end-to-end payer operations while tightening control of administrative costs. (Link)
- US Fertility partners with L Catterton and Amulet Capital Partners in new co-lead investor structure to expand access to advanced reproductive care across the U.S. The updated ownership structure preserves significant physician ownership while adding growth capital and consumer-health expertise to scale US Fertility’s clinics, labs, and research programs. It supports broader access to IVF, IUI, genetic testing, and related services, while reinforcing a physician-led, patient-centered care model for tens of thousands of new patients annually. (Link)
- MedEdge Holdings launches with $450 million management-led buyout to integrate Abyrx’s biomaterials portfolio and Kairuku’s surgical SaaS platform The holding company will merge biomaterials and surgical software capabilities to streamline product sourcing, inventory control, and case coordination for hospitals and OR teams. Profitable operations plus new capital will fund acquisitions of 10–15 commercial-stage products, aiming to cut administrative complexity while broadening access to next‑generation surgical technologies. (Link)
- FluidAI Medical acquires Emmetros Limited, developer of SparxConnect, to strengthen AI-driven Stream Inara patient engagement The integration focuses on stronger postoperative monitoring and communication, using collaboration tools to guide patients before procedures and through home recovery. It supports earlier discharge while preserving visibility into outcomes and patient‑reported data, and complements existing monitoring, surgical decision support, and recovery programs to boost throughput, bed utilization, and personalized recovery planning. (Link)
- Innova Therapeutics acquires Enci Therapeutics to advance IVT-8086, a first-in-class monoclonal antibody targeting SFRP2 in solid and hematologic cancers The deal centralizes control of IVT-8086 to accelerate its development as a targeted therapy against a key signalling pathway driving angiogenesis, tumour growth, immune evasion, and metastasis. Strong preclinical data support its potential both as monotherapy and in combination with checkpoint inhibitors, alongside a companion diagnostic to guide detection, prognosis, and relapse monitoring. (Link)
- MiCare Path acquires Compwell, LLC to accelerate national expansion of AI-powered virtual care platform The platform now supports large, multispecialty patient panels with reimbursable programs for remote monitoring and ongoing care management. New capital and the Compwell integration will grow clinical services, deepen health system collaborations, and accelerate AI-driven workflow automation, enabling more proactive, personalized virtual care that extends clinician support into patients’ daily lives. (Link)
- Brown’s Medical Imaging and Prestige Medical Imaging merge to expand nationwide, multi-vendor medical imaging service capabilities The merged business broadens nationwide coverage while maintaining a vendor-agnostic service model with strong uptime and response commitments. A 150‑plus engineer field force provides fast remote and onsite support, underpinned by a customer‑first, end‑to‑end service philosophy. Leadership promotions reinforce continuity and position the company for its next phase of growth. (Link)
- AleraCare, backed by Hildred Capital Management, to merge with Pure Healthcare to Form National Platform for Ambulatory Infusion and Specialty Care The merged platform operates 77 infusion centers in 14 states, pairing complex-chronic-care expertise with expanding home and alternate-site services. A unified contracting and technology backbone supports payors, providers, and biopharma with faster therapy starts, better adherence, and AI-enabled scheduling, benefits checks, and real-time outcomes tracking, while maintaining a safety- and compassion-focused culture. (Link)
News Healthcare Deals, Investments & Update Week ending Nov 24th 2025
- Abbott (NYSE: ABT) to acquire Exact Sciences (NASD: EXAS) in $21 Billion All-Cash Deal to Expand Global Cancer Screening and Precision Oncology Diagnostics Portfolio The deal will make Exact Sciences a subsidiary, helping Abbott reach $12 billion in diagnostics sales. Exact’s Madison, Wisconsin presence and leadership will remain, with the CEO advising during transition. Shareholder and regulatory approvals are expected before closing in mid-2026. (Link)
- Merck (NYSE: MRK) to acquire Cidara Therapeutics (NASD: CDTX) for $9.2 Billion, Gaining Late-Phase Antiviral CD388 for Influenza Prevention After the deal’s approval, Cidara Therapeutics will strengthen Merck’s presence in antivirals with CD388 targeting high-risk influenza populations. The acquisition structure ensures all Cidara shares are purchased, pending regulatory clearance, with closing planned for the first quarter of 2026. (Link)
- GE Healthcare (NASD: GEHC) to acquire Intelerad in $2.3 Billion Deal to Expand Cloud-Enabled and AI-Driven Imaging Platform for Radiology, Cardiology, and Outpatient Enterprise Markets The integration will modernize imaging workflows for outpatient and ambulatory care, leveraging Intelerad’s SaaS and AI strengths to streamline operations, unify data, and improve provider efficiency. Backed by global reach and financial flexibility, GE HealthCare expects significant recurring revenue and top-line growth from expanded cloud imaging offerings. (Link)
- Solventum (NYSE: SOLV) to acquire Acera Surgical for $725 Million Plus Milestone Payments, Expanding Advanced Wound Care Portfolio with Synthetic Tissue Matrices Technology Acera’s Restrata product, a fully resorbable electrospun fiber matrix, treats hard-to-heal acute care wounds by supporting cellular growth and healing. Solventum will use its sales expertise and international presence to accelerate Restrata’s adoption, aiming for commercial and operational synergies that drive leadership in advanced regenerative wound care. (Link)
- Halozyme Therapeutics (NASD: HALO) completes $750 Million Acquisition of Elektrofi, Unlocks Hypercon™ Technology for High-Concentration Biologics and Expands Drug Delivery Offerings Hypercon™ enables highly concentrated biologics to be delivered subcutaneously, improving patient convenience and supporting at-home care. Halozyme Therapeutics will pursue royalty-based licensing for products built on Elektrofi’s technology, with expected milestone payments and clinical launches that could begin driving revenues and broader market impact starting in 2030. (Link)
- Nanox Imaging (NASD: NNOX) to acquire VasoHealthcare IT from Vaso Corporation (OTCQX: VASO) for Up to $800,000 to Accelerate U.S. Rollout of FDA-Cleared AI Medical Imaging Solutions Nanox’s platform brings real-time AI analysis and automated detection to routine CT imaging, offering multiple FDA-cleared solutions for radiology and cardiology. The acquisition leverages VasoHealthcare IT’s healthcare relationships for broader market coverage, enabling faster hospital adoption and improved integration of AI-driven workflows for earlier chronic disease identification. (Link)
- RadNet (NASD: RDNT) acquires River Radiology, Strengthening New York Imaging Network and Expanding Lenox Hill Radiology’s Geographic Reach River Radiology’s Kingston facility delivers patient-centered care with advanced imaging services such as MRI, CT, PET/CT, 3D mammography, and ultrasound. Extended weekday hours and flexible scheduling support provider referrals. Its reputation for accurate reports, innovative screening, and compassionate service has defined medical imaging excellence across the Hudson Valley region. (Link)
- ClearPoint Neuro (NASD: CLPT) completes acquisition of IRRAS, Bringing IRRAflow System and Expanding Neurocritical Care and Drug Delivery Capabilities IRRAflow uses active irrigation and drainage to effectively treat brain haemorrhages, leading to faster clearance of blood, fewer catheter infections, and reduced risk of blockages compared to passive drains. Clinical studies report improved patient outcomes, shorter treatment duration, and lower hospital costs for those treated with this innovative technology. (Link)
- Reliant Healthcare and Care Fusion Rx Merge to Transform U.S. Infusion Therapy with Expanded Home and Ambulatory Service Platform Reliant Healthcare operates 14 infusion centers and specialty pharmacies across the southern U.S., while Care Fusion Rx brings expertise in advanced therapies—including immunoglobulin treatments—for chronic and rare diseases. The merger will drive national expansion with new locations, broader coverage, and investment in patient-focused care guided by experienced leadership. (Link)
- ARC Health Partners acquires Clarity Counselling Center, Adding Wilmington-Based Practice to 23-Group National Network and Expanding North Carolina Reach with Backing from Thurston Group Clarity Counselling Center offers therapy for individuals, couples, and families, specializing in anxiety, depression, trauma, ADHD, grief, and relationship issues in Wilmington, NC. Their team of over 13 therapists uses evidence-based therapies like CBT and DBT, ensuring client-therapist matching and personalized care for children, teens, and adults. (Link)
- MRO acquires Clinetic, via its financial sponsors Healthworx and Parthenon Capital Partners to Transform Patient Recruitment and Streamline Clinical Trial Enrollment with Scalable AI-EHR Integration Clinetic’s software uses AI to analyse both structured and unstructured patient data for real-time matching to clinical studies, dramatically accelerating recruitment. By integrating with EHRs, it supports secure workflow automation, precise cohort building, and reduces site workload—expediting enrollment for a nationwide hospital network and the Q-Centrix Research Network. (Link)
- OhioHealth, a Columbus-based nonprofit health system, is acquiring the independent 220-bed Fairfield Medical Center in Lancaster, OH. The deal will expand OhioHealth’s network to 17 hospitals and enhance regional care. The boards endorsed the merger in September 2024 after a non-binding letter of intent, with benefits including increased efficiencies, improved quality measures, and access to larger system resources for a growing population. Pending regulatory approvals and government filings, the deal is expected to close in 2026; no financial terms were disclosed. (Link)
- WVU Health System to acquire Independence Health System, Growing to 30-Hospital Network with $800 Million Investment Commitment Morgantown-based WVU Health System will acquire Greensburg’s Independence Health System, including five hospitals, physician groups, and subsidiaries, rebranding under WVU Medicine. WVU pledges $800 million over five years for facility modernization. Closing anticipated in fall 2026. (Link)
- Function Health raises $298 Million Series B led by Redpoint Ventures and a16z at $2.5 Billion valuation for Medical Intelligence Lab launch. Function Health offers comprehensive lab testing, body scans, and health data consolidation to detect over 1,000 conditions early via more than 100 biomarkers. The funding will expand U.S. locations, develop AI health features, and lower annual membership pricing. It also backs the Medical Intelligence Lab to advance health and longevity research for proactive care. (Link)
News Healthcare Deals, Investments & Update Week ending Nov 17th 2025
- Pfizer (NYSE: PFE) completes $7 Billion acquisition of Metsera (NASD: MTSR), adds MET-097i, MET-233i, and Expands Clinical Obesity Pipeline in Strategic Move for Cardiometabolic Therapeutics Leadership: The acquisition of Metsera brings new advanced obesity and cardiometabolic drug candidates, including injectable and oral therapies, accelerating innovation in this high-growth field. The deal enables rapid research, expanded expertise, and improved access to cutting-edge treatments, driven by milestone-based investments and integration of Metsera’s scientific strengths. (Link)
- Day One Biopharmaceuticals (NASD: DAWN) to acquire Mersana Therapeutics (NASD: MRSN) in $285 Million Deal to Advance Novel ADC Emiltatug Ledadotin for Adenoid Cystic Carcinoma and expanded Oncology Portfolio: Emiltatug ledadotin (Emi-Le) targets B7-H4 in adenoid cystic carcinoma, showing promising early anti-tumour activity for patients lacking effective therapies. Day One’s acquisition plan supports rapid clinical progress, with milestones tied to regulatory and commercial outcomes, aiming to advance this innovative cancer treatment for diverse, underserved populations. (Link)
- Galecto (NASD: GLTO) acquires Damora Therapeutics, With $285M Investment Led by Fairmount, Viking Global, Venrock, Wellington, RA Capital, Andreessen Horowitz, and Others to Advance Anti-mutCALR Therapies for Blood Cancers: The merger advances pioneering treatments for rare blood cancers, with lead antibody DMR-001 designed for greater potency and patient convenience. Expanded research and strategic guidance support rapid clinical progress, including novel therapies for acute myeloid leukaemia, improved trial designs, and broader access for affected patients. (Link)
- Fabric acquires UCM Digital Health, adding 400 Payer and Employer Clients, to expand AI-Powered Virtual Care Nationwide: The acquisition expands Fabric’s reach, offering AI-powered virtual care for over one million new lives and enhancing efficiency for patients, payers, and providers. By integrating UCM’s clinical expertise, Fabric improves seamless care delivery, cost savings, and access, strengthening its network across health systems and employer partnerships nationwide. (Link)
- Luma Health acquires Tonic Health from R1, Expanding Patient Intake and Follow-Up Solutions for Over 1,000 Health Systems and 100 Million Patients, for EHR-Integrated Care Innovation: The integration empowers healthcare organizations with advanced digital tools for automating patient intake, consent, and follow-up. By reducing manual tasks and streamlining data coordination, clinical teams benefit from improved workflow efficiency and better patient communication. Enhanced electronic health record connectivity ensures patients experience smoother journeys and greater access to personalized care. (Link)
- Emergence, backed by The Pritzker Organization, acquires MedEvolve, to Transform AI-Driven Revenue Cycle Management for Healthcare Providers: MedEvolve will accelerate development of advanced automation and analytics tools to help healthcare organizations address operational inefficiencies and financial pressures. Its platform offers real-time insights for process improvement and margin recovery, supporting increased transparency, effective collections, and sustainable performance management in complex revenue cycle operations. (Link)
- Get Well and RhythmX AI Combine Under SymphonyAI Group, to Form GW RhythmX and Advance Precision Care AI for 150 Health Systems and 85 Million Patients: The combined entity delivers integrated engagement and precision care using AI-driven data insights, streamlining patient support and clinical workflow for providers. Its enterprise-scale approach offers tailored recommendations, improved outcomes, and operational efficiency, with demonstrated success in enhancing care quality, readmission rates, and patient satisfaction across diverse healthcare settings. (Link)
- Diversis Capital Unites Genesis Automation Healthcare, Kermit, and Meperia to Launch First End-to-End Clinical Supply Chain Platform and Highlight $1B in Global Annual Savings for 100+ Hospitals and Health Networks: The Genesis platform streamlines hospital and ambulatory center supply chains with unified digital management for inventory, charge capture, and contract pricing. Automated workflows and analytics improve data quality, reduce waste, and strengthen compliance, enabling clinicians to prioritize patient care while finance teams achieve greater transparency and control over spending. (Link)
- Vituity Integrates Focus Medical Imaging, Expands Physician-Led Model Into Diagnostic and Interventional Radiology for Hospitals and Health Systems Nationwide: The partnership enhances clinical services with a physician-led approach, empowering medical professionals in decision-making and governance. Expanded diagnostic and interventional radiology offerings, combined with innovative teleradiology, improve operational efficiency and patient care. Hospitals and imaging centers gain more coordinated, effective, and sustainable service delivery across the healthcare continuum. (Link)
- OneOncology and Cancer Specialists of North Florida (CSNF) Forge Partnership, via its financial sponsor TPG, to Elevate Community-Based Cancer Care and Expand Integrated Oncology Services Across North Florida: The collaboration improves oncology care for thousands of patients with access to advanced diagnostics, accelerated clinical research, and streamlined treatment delivery. Patients benefit from reduced wait times, comprehensive support, and integrated technology resources, while clinicians retain independence and expand expertise. The alliance promotes regional access to innovative therapies and superior care coordination. (Link)
- Hyve acquires Health Grown Advisory Network (HGAN), Strengthening Healthcare Innovation Partnerships and Behavioural Health Tech Integration: The integration provides ongoing support and tailored connections for digital health innovators and organizations, enhancing marketing, strategy, and system navigation. Expanded advisory resources deepen collaboration, foster scalable partnerships, and enable health industry leaders to engage beyond traditional event cycles, increasing opportunities for impactful innovation and consumer health benefits. (Link)
- The Lockwood Group acquires Research To Practice (RTP), via its financial sponsor Ares Management, expanding Global Oncology Education: The partnership enhances global oncology education by combining proven training formats with advanced consulting and communication expertise. Oncology professionals gain access to innovative, evidence-based resources reflecting current clinical advances. This collaboration delivers practical knowledge, supports professional growth, and helps clinicians make informed decisions to improve patient outcomes worldwide. (Link)
News Healthcare Deals, Investments & Update Week ending Nov 10th 2025
1. BillionToOne (NASD: BLLN) raises $273 Million in U.S. IPO Led by J.P. Morgan, Piper Sandler, Jefferies, and William Blair
The firm’s technology powers advanced prenatal and oncology diagnostics through its Unity and Northstar tests. Analysts view its IPO success as reflecting growing investor confidence in biotech innovation despite wider market uncertainty. The offering signals renewed momentum in healthcare listings, inspired by other major sector filings such as Medline’s. (Link)
2. Sonida Senior Living (NYSE: SNDA) and CNL Healthcare Properties announce $1.8 Billion Merger Creating the Nation’s Eighth Largest Senior Housing Owner
The merger focuses on expanding nationwide senior living operations with an emphasis on quality care and operational integrity. Both companies aim to strengthen their market position through shared values and strategic growth in key U.S. regions, while investors anticipate improved financial performance and stronger long-term value within the senior housing sector. (Link)
3. QOL Medical to acquire Evoke Pharma (NYSE: EVOK) in All-Cash Deal Worth $11 Per Share
The agreement merges complementary strengths in gastrointestinal innovation, expanding access to advanced treatments for diabetic gastroparesis. Both companies underscored the transaction’s strategic value in broadening therapeutic offerings and commercial reach. Supported by cash reserves, the acquisition awaits regulatory and shareholder approval, marking a step toward enhanced capabilities in GI-focused patient care. (Link)
4. Organon sells Jada System to Laborie Medical Technologies in $465 Million Deal
The transaction supports reorganization and debt reduction, positioning both companies for strategic growth. Laborie will expand its maternal health portfolio by incorporating the Jada device and its specialized workforce. Organon aims to redirect focus toward women’s health biopharma opportunities after recent leadership transitions, declining sales, and halted drug development initiatives. (Link)
5. Lifecare Home Health acquires Infinity Hospice Care, via its financial sponsor Zenyth Partners, expands Hospice Services Across Nevada and Arizona
The collaboration enhances post-acute care delivery through unified expertise in compassionate and high-acuity hospice services. Combining national infrastructure with community-based operations, both organizations aim to elevate patient experiences centered on dignity and care quality. Leadership underscores innovation and continuity as key drivers in expanding coordinated healthcare across multiple states. (Link)
6. Optain Health acquires EyePACS to Advance AI-Driven Retinal Screening and Oculomics Innovation
The collaboration enhances early disease detection through advanced AI imaging, expanding access to preventive care and population health programs. EyePACS’s nationwide network will integrate Optain’s automation and multilingual capabilities, improving clinical efficiency and diagnostic scalability while advancing oculomics research aimed at identifying systemic diseases through non-invasive retinal analysis. (Link)
7. JLL Partners combines Vascular Technology Incorporated and Parks Medical Electronics to Build Vascular and Robotics Device Platform
The merger unites advanced capabilities in vascular diagnostics and Doppler ultrasound technologies to enhance precision and clinical performance. By combining innovation with U.S.-based production, the partnership focuses on improving device reliability and expanding access to next-generation vascular tools that support surgical, therapeutic, and diagnostic applications worldwide. (Link)
8. Omega Systems acquires PEAKE Technology Partners, via its financial sponsor Revelstoke Capital Partners to strengthen Healthcare Managed IT and Cybersecurity Capabilities
The acquisition enhances healthcare IT services through advanced data security, compliance, and AI-driven clinical capabilities. By integrating expertise in electronic health records and HIPAA management, the partnership aims to boost operational performance and patient outcomes while expanding regional reach and reinforcing leadership in secure, technology-driven healthcare infrastructure nationwide. (Link)
9. Acumed acquires TECHFIT Digital Surgery Assets to Advance Patient-Tailored Craniomaxillofacial Solutions
The integration brings advanced digital planning and reconstruction capabilities to improve precision in surgical procedures across multiple specialties. By expanding personalized, data-driven care, the company aims to advance innovation in reconstructive and orthopaedic solutions. Leadership additions and global strategy alignment will support broader adoption of patient-tailored surgical technologies worldwide. (Link)
10. RadNet and DeepHealth acquire Alpha RT to Expand Remote MRI Scanning and AI Safety Capabilities
The integration enhances imaging efficiency through AI-powered monitoring, advanced training, and resource optimization to tackle technologist shortages. By combining intelligent staffing with remote imaging technology, the partnership strengthens scalability and nationwide support. It aligns with continued investments in AI-driven diagnostics, expanding capabilities across multiple medical imaging modalities and platforms. (Link)
News Healthcare Deals, Investments & Update Week ending Oct 27th 2025
1. Hologic (NASD: HOLX) to go private in $18.3 Billion acquisition by Blackstone and TPG, Minority Stakes for Abu Dhabi Investment Authority and GIC The transaction is designed to deliver compelling value to shareholders and highlights continued innovation in women’s health and AI-driven diagnostics. Hologic will maintain its brand and headquarters while operating privately. The agreement includes a 45-day “go-shop” period, and closing remains subject to regulatory and shareholder approvals, with completion anticipated in the first half of 2026. (Link)
2. Novartis (NYSE: NVS) to acquire Avidity Biosciences (NASD: RNA) for $12 Billion; SpinCo to Emerge as Independent Cardiology-Focused Company The deal, unanimously approved by both boards, will give Novartis global rights to innovative RNA-based neuromuscular therapies and boost its neuroscience pipeline with potential first-in-class candidates. Avidity shareholders will receive additional SpinCo stock or cash linked to its cardiology assets. Regulatory and shareholder approvals are pending. (Link)
3. Eli Lilly (NYSE: LLY) to acquire Adverum Biotechnologies (NASD: ADVM) in Deal Centered on Ixo-vec Gene Therapy Lilly’s purchase will help advance Ixo-vec, a novel gene therapy for vision loss, offering shareholders potential milestone payments based on regulatory and sales goals. This late-stage treatment addresses a major unmet need for wet age-related macular degeneration. The acquisition also secures short-term funding for Adverum’s clinical progress. (Link)
4. Alkermes (NASD: ALKS) to acquire Avadel Pharmaceuticals (NASD: AVDL) for Up to $2.1 Billion, Expanding Sleep Medicine Portfolio with LUMRYZ™ Alkermes’ acquisition adds the FDA-approved LUMRYZ™, a once-at-bedtime sodium oxybate treatment for narcolepsy symptoms like cataplexy and excessive daytime sleepiness. The deal offers shareholders $18.50 upfront plus $1.50 contingent on FDA label expansion, a 38% premium over recent prices. Closing is expected in Q1 2026, enhancing Alkermes’ sleep medicine portfolio and leveraging Avadel’s expertise for future pipeline development. (Link)
5. DocGo (NASD: DCGO) acquires SteadyMD to Expand Telehealth Services Nationwide; SteadyMD Co-Founders Join Leadership Team DocGo acquired SteadyMD to expand its telehealth reach across all 50 states, integrating SteadyMD’s virtual clinician network with its mobile healthcare services. SteadyMD, expected to generate $25 million in 2025, serves over 3 million patients, including Fortune 10 clients. SteadyMD’s leadership joins DocGo’s team, and the acquisition is funded by DocGo’s cash reserves. (Link)
6. Lemonaid Health acquired by Bambu Ventures to relaunch as Independent Telemedicine Platform after Bankruptcy Lemonaid Health, after bankruptcy will pursue aggressive growth as an independent telemedicine and pharmacy platform. Bambu and Innova Partners provide executive leadership, focusing on affordable care, same-day prescriptions, and market expansion. Key board appointments and new investors support innovation and differentiation. (Link)
7. Opyn Health, Inc. acquires Empara to Integrate AI-Driven Benefits Engagement and Boost Platform for Self-Insured Healthcare Combining Opyn’s price transparency and virtual care expertise with Empara’s AI-powered app streamlines benefits administration and cost management for members and administrators. Empara’s founders join Opyn, and the unified platform will serve TPAs, brokers, and self-insured employers—aiming to replace legacy systems with a seamless digital access point for healthcare. (Link)
8. Oasis Health Partners® acquires PreferCare to Strengthen Value-Based, Preventive Primary Care for Seniors in North Carolina PreferCare enhances Oasis’s capabilities with in-home and virtual care for seniors, leveraging new tools, analytics, and clinical support. The partnership improves coordinated care, preventive screenings, and early interventions. By empowering physicians and supporting practices, Oasis advances health equity and outcomes, building healthier communities through a value-based care model. (Link)
9. Duly Health and Care acquire Woodridge Clinic, via its financial sponsors Ares Private Equity Group, Guidon Partners and Athyrium Capital Management, expanding Physician-led Primary Care Services across Chicagoland Woodridge Clinic, founded in 1986, excels in primary care, diabetes management, and occupational therapy. Joining Duly gives its team access to new resources and technology, expanding specialty care and services in Lemont, Lombard, and Woodridge. This partnership strengthens coordinated, patient-focused care for local families and supports ongoing provider recruitment. (Link)
10. Frontline Healthcare Partners acquires Integracare Inc. to drive expansion of Private-Pay Home Care across Ontario, Canada Integracare will benefit from expanded operational resources and Frontline’s healthcare investment expertise to reach new communities. The partnership preserves its focus on personalized, quality home care and workplace excellence, supporting growth beyond Toronto, Mississauga, and Ottawa. This move helps advance Integracare’s mission and expands personalized home health solutions across Ontario. (Link)
11. Cerebral raises $25 Million in Latest Funding Round, Accelerating Growth and Platform Integration The capital infusion, following the Resilience Lab acquisition, will support Cerebral’s nationwide expansion, platform integration, and quality initiatives like improved clinical training. Funds will enhance telehealth services, solidify insurance partnerships, and drive innovation in therapy, psychiatry, and medication management, as the company rebuilds after leadership and regulatory challenges. (Link)
12. Counsel Health raises $25 Million Series A Led by Andreessen Horowitz and GV to Launch Physician-Supervised AI Front Door for Healthcare Following $11 Million Seed Round Counsel Health’s platform delivers instant, context-aware medical guidance via chat or voice, using AI with physician oversight for diagnosis, prescriptions, or referrals and unlimited follow-up. It reports a 96% resolution rate, rapid response times, and measurable cost savings. Serving 100,000+ members now, it’s expanding to reach millions nationwide. (Link)
13. Faeth Therapeutics raises $25 Million, led by S2G Investments, with Support from KdT Ventures, Khosla Ventures, Future Ventures, Cantos Ventures, Digitalis Ventures, B Capital Group, Avicella Capital, THO Seed Fund and Others Faeth Therapeutics’ funding will support a randomized phase 2 trial of its PIKTOR regimen after an 80% response rate and 11-month median progression-free survival in endometrial cancer. The capital enables insulin control research, expansion into rectal cancer and rare metabolic disorders, and growth of the MetabOS™ precision oncology platform. (Link)
News Healthcare Deals, Investments & Update Week ending Oct 20th 2025
1. R1 acquires Phare Health, via its financial sponsors TowerBrook Capital Partners, Khosla Ventures and Clayton, Dubilier & Rice, to expand Agentic AI Revenue Cycle Capabilities The Murray, Utah-based healthcare revenue management leader will integrate the AI-native inpatient coding and clinical documentation improvement platform into its R37 innovation lab, expected to close by end of October 2025. Phare Health’s AI engine reads all unstructured and structured data points to build holistic patient journey fingerprints, cross-referencing with guidelines and coding policies for context-aware decisions with full evidence trails, unlike traditional keyword extraction systems. The combination delivers market-leading DRG Validation integration for faster, accurate reimbursement and real-time claim adjudication positioning. R37 lab currently operates agentic applications with select R1 clients achieving 97% accuracy rates in autonomous coding for emergency room and physician office visits. (Link)
2. BioCryst Pharmaceuticals (NASD: BCRX) to acquire Astria Therapeutics (NASD: ATXS) in $700M Deal backed by Blackstone Financing The acquisition adds Astria’s late-stage candidate, navenibart, a long-acting injectable for hereditary angioedema (HAE) prophylaxis, to BioCryst’s portfolio. This creates a comprehensive HAE franchise, combining an oral therapy with a potentially best-in-class injectable. The deal is expected to sustain BioCryst’s double-digit revenue growth for the next decade while maintaining the company’s profitability and positive cash flow. Astria CEO Jill C. Milne will join BioCryst’s board upon the transaction’s close, anticipated in Q1 2026. The combined company will also seek strategic alternatives for Astria’s early-stage atopic dermatitis program. (Link)
3. OSR Holdings (NASD: OSRH) acquires WORIO to Pioneer Needle-Free Glucose Monitoring
The Bellevue-based company acquires the pioneer in non-invasive glucose monitoring utilizing proprietary near-infrared spectroscopy (NIRS)-based technology enabling truly needle-free continuous glucose monitoring. WORIO becomes a wholly owned subsidiary of OSRK, with shareholders receiving newly issued OSRK shares convertible into approximately 1.09 million OSRH common stock shares at 12.96:1 ratio if OSRH reaches at least $10 per share within three years. The acquisition targets the global glucose-monitoring market projected at $40-plus billion by 2030, with no immediate dilution for existing shareholders. WORIO established partnership with a major global consumer electronics company providing non-dilutive funding and employee participation in initial proof-of-concept trials, with clinical trials launching at a leading Seoul medical center. (Link)
4. GTCR Makes $200M Strategic Minority Investment in Solmetex to Accelerate Growth and Acquisitions
GTCR announced a $200 million structured minority investment in Solmetex, a leading provider of dental products and systems spanning amalgam separation, waterline safety, dental isolation, and regenerative biomaterials. The investment, made in partnership with existing shareholder AGIC Capital, supports Solmetex’s expansion through organic growth and near-term add-on acquisitions. Founded in 1994, Solmetex serves more than 85,000 dental offices nationwide and has built a diversified portfolio through targeted integrations. GTCR will collaborate with Solmetex CEO Gene Dorff and management to accelerate growth and broaden the company’s position in the U.S. dental supply ecosystem. (Link)
5. Hospital for Special Surgery and General Atlantic Launch National Orthopaedic Platform with Legent Health Acquisition The new, independently operated platform will focus on building a national network of ambulatory surgery centers (ASCs) for orthopaedic and spine care. It aims to expand patient access to high-quality, lower-cost procedures in outpatient settings closer to home. The venture combines HSS’s clinical expertise and surgeon network, General Atlantic’s scaling experience, and Legent’s operational infrastructure. Legent CEO Jordan Fowler will lead the platform, which plans to partner with physicians, offering them equity participation and access to HSS protocols. Growth will be pursued through acquisitions, new partnerships, and developing new facilities. (Link)
6. Boston Scientific (NYSE: BSX) to acquire Nalu Medical in $600M Deal to Expand Chronic Pain Portfolio
The acquisition will integrate Nalu’s innovative Neurostimulation System into Boston Scientific’s neuromodulation offerings. The system features a miniaturized, battery-free implant that is wirelessly powered by an external disc and controlled via a smartphone app. It delivers peripheral nerve stimulation to interrupt pain signals, having demonstrated significant and sustained pain relief in clinical trials. With real-world data from over 2,000 patients, the technology addresses a significant unmet need for chronic pain conditions. The transaction is expected to close in the first half of 2026 and is projected to be accretive to adjusted earnings per share starting in 2027. (Link)
7. Level Education Group acquires Triad Behavioral Health, via its financial sponsor Baum Capital Partners Management to Create End-to-End Educational Platform for Behavioral and Mental Health Professionals
Level Education Group is a South Jordan, Utah-based continuing education leader serving over one million healthcare professionals. The acquisition creates a comprehensive platform supporting students preparing for licensure, newly licensed practitioners, and seasoned professionals advancing knowledge and skills. Triad offers exam-blueprint and accreditation-aligned assessment solutions for universities, exam prep and continuing education for employer clinical staff, plus job board recruitment tools. CEO Jamie Harper emphasized addressing the urgent challenge of ensuring behavioral and mental health professionals have necessary resources, support, and training as service demand grows. (Link)
8. AVIA Acquires Panda Health to Expand Healthcare Technology Intelligence Platform The Chicago-based healthcare technology navigator built by health systems combines with Panda Health to create a community representing over 75% of the nation’s health systems and over 7,000 solution companies. The human-validated digital transformation platform provides comprehensive healthcare technology intelligence powered by robust agentic AI workflows enhanced with human insight, delivering decision-quality insights validated in real health system context to accelerate confident digital adoption. The joint platform expands capabilities with new insights, collaboration opportunities, and digital tools for healthcare providers evaluating and selecting digital health solutions, ensuring neutral research and peer-driven reviews support data-informed decisions in a rapidly changing healthcare landscape. (Link)
9. Cortechs.ai acquires ZepMed to Expand AI-Powered Neuroimaging Portfolio The San Diego-based AI-driven neuroimaging software company acquires the FDA Class II-cleared NeuroAlign CT™ software that automates segmentation, alignment, and reformatting of head CT scans, enabling clinicians to detect subtle brain anatomy changes with greater confidence and speed while streamlining radiology workflows. The acquisition expands Cortechs’ neuroimaging portfolio beyond its current capabilities to create a continuum of care spanning surveillance, diagnosis, and risk assessment. ZepMed’s pioneering CT imaging technology enhances diagnostic accuracy through automated processing, strengthening Cortechs’ position in radiological innovation. The integration positions the company to complete the precision medicine value chain through a multimodal ecosystem serving patients, clinicians, and payers. (Link)
10. CareScout to acquire Seniorly in Sub-$20M Deal Backed by Genworth The acquisition will integrate Seniorly’s platform and its network of thousands of senior living communities and local advisors into CareScout’s services. This integration aims to provide families with a broader range of trusted long-term care options and personalized guidance, whether they are seeking home care or senior living communities. The transition will occur over the coming months, with the Seniorly website rebranding as “Seniorly, powered by CareScout.” The deal, expected to close in Q4 2025, is designed to accelerate CareScout’s mission to create a more dignified and connected aging experience for older adults. (Link)
11. Solis Mammography acquires St. Louis Breast Center, via its financial sponsors TowerBrook Capital Partners and Madison Dearborn Partners in Missouri Expansion This strategic move establishes the national provider’s first presence in the state of Missouri, paving the way for future regional growth. The acquisition integrates a well-regarded, independent center known for its comprehensive and compassionate care into Solis’s national network. The St. Louis Breast Center was originally launched by a group of obstetricians and gynaecologists to offer state-of-the-art breast imaging. Solis Mammography, the largest independent provider in its field, has nearly four decades of experience dedicated to early detection, serving millions of women across the United States. (Link)
12. Topcon Healthcare to acquire Toku, Inc. to Expand AI-Driven, Non-Invasive Chronic Disease Screening
Topcon Healthcare, a global leader in digital health and ocular data solutions, signed a definitive agreement to acquire Toku, a San Diego-based AI health technology company founded in New Zealand. The deal adds Toku’s CLAiR™, BioAge™, and MyKidneyAI™ platforms, which use retinal images to assess cardiovascular, biological aging, and kidney-disease risk, to Topcon’s Healthcare from the Eye™ ecosystem. Integrated into Topcon’s Harmony® platform, Toku’s technology—trained on more than 4.3 million retinal images—enables scalable, non-invasive screening across primary care and telehealth settings. The acquisition accelerates Topcon’s expansion into preventive medicine and strengthens its AI portfolio for early detection of chronic disease. (Link)
13. Manatee Acquires Happypillar to Scale Personalized Mental Health Care for Families
Manatee, a leading virtual mental health platform for families, has acquired Happypillar, an AI-driven parent-child therapy coaching company, to expand access to personalized, evidence-based behavioral health solutions. The combination integrates Happypillar’s AI and behavioral science tools with Manatee’s family-first clinical platform, creating a hybrid model of clinician-led and self-guided care that supports both therapy sessions and daily family interactions. The acquisition strengthens Manatee’s position as a nationwide provider partnering with major health plans to deliver scalable, outcomes-driven mental health care for families. (Link)
VENTURE AND OTHER
1. MD Integrations raises $77M from Updata Partners and Denali Growth Partners to Scale Physician-First Telehealth Infrastructure The funding will accelerate product innovation and expand its nationwide, doctor-exclusive network. The company also appointed Ramin Zacharia as President and COO to lead its next growth phase. Founded by Dr. Marc Serota, MDI provides an end-to-end platform that integrates clinical operations, pharmacies, diagnostics, and payments for digital health brands. This infrastructure enables partners to launch new virtual care services rapidly while maintaining compliance across all 50 states. The company has achieved triple-digit year-over-year growth, facilitating millions of patient consultations across multiple specialties. (Link)
2. OneImaging secures $38M Series A from Vy Capital, Aquiline, Sempervirens, XRC Ventures and SixThirty Ventures to Disrupt Radiology with Transparent Pricing
The Miami-based startup operates a platform that connects patients and providers to a nationwide network of accredited imaging centers. It aims to simplify the appointment process while dramatically reducing costs—by up to 80%—through transparent pricing and seamless reimbursement. The company has experienced significant growth, forming partnerships with multiple Fortune 100 employers and major health plans, expanding affordable access to millions. Founder and CEO Elan Adler, a former MRI technologist and Siemens executive, started the company after a personal family experience with dangerous diagnostic delays. (Link)
3. Peptilogics Raises $78M to Advance Zaloganan (PLG0206) into Phase 2/3 Pivotal Trial for Prosthetic Joint Infections Peptilogics, a Pittsburgh-based clinical-stage biotechnology company developing surgical therapeutics for device-related infections, closed an oversubscribed $78 million Series B2 round led by Presight Capital, Thiel Bio, and Founders Fund, with new investors including AMR Action Fund, Narya Capital, and Beyond Ventures. The financing supports a Phase 2/3 pivotal trial of zaloganan (PLG0206) for prosthetic joint infections (PJI)—a $390,000-per-patient complication with no approved therapies. In a prior Phase 1b study, zaloganan achieved 93% infection-free rates at 12 months when used during DAIR procedures. The upcoming randomized trial, enrolling 240 patients starting December 2025, will measure clinical failure reduction and health-economic outcomes. Zaloganan has received QIDP, Orphan Drug, and Fast Track from the FDA. (Link)
4. Alleviate Health secures $4.3M Seed Funding Led by Andreessen Horowitz, with participation from Alt Capital and First Harmonic Group for AI-Powered Clinical Trial Recruitment The platform uses human-in-the-loop AI agents to automate patient pre-screening via SMS and voice, verifying eligibility against study protocols and scheduling visits. This addresses critical inefficiencies and staff burnout at research sites by handling routine tasks. In its first year, the solution has already managed over 500,000 patient interactions across 190+ sites in the U.S. and Canada, accelerating recruitment for more than 300 trials. The company has established partnerships with major site networks including Alcanza, CenExel, and M3 Wake. The new capital will support its mission to transform the clinical trial recruitment process. (Link)